BIOTRONIK introduced in India its latest and most advanced Home Monitoring Technology for patients
Author(s): City Air NewsFrom Left Dr Viveka Kumar from Max Hospital,Mr Tushar Basu, MD, BIOTRONIK, Dr Niraj Varma, Cleveland Clinic, USA. New Delhi, March 19, 2016: World’s leading cardio and endovascular technology maker BIOTRONIK today...
New Delhi, March 19, 2016: World’s leading cardio and endovascular technology maker BIOTRONIK today introduced in India its latest and most advanced Home Monitoring Technology for patients with implanted cardiac devices such as pacemakers, implantable defibrillators (ICDs) and heart failure devices.
BIOTRONIK Home Monitoring® is an internet based remote monitoring technology that enables physicians to continuously and reliably monitor their patients’ clinical and device status anytime, anywhere, and minimize risk of any negative medical event.
The latest device in the BIOTRONIK Home Monitoring program, the CardioMessenger Smart is about the size of a smartphone and is highly robust, more convenient and remarkably portable as compared to previous versions of the device. Having the pacemaker wearers constantly connected to their physician, this home monitoring technology enhances safety for cardiac device patients. The device provides fully automatic transmission of vital information from a patient’s cardiac implant to their physician via BIOTRONIK Home Monitoring.
Data are transmitted from the patient’s implant to the CardioMessenger’s transmitter device which uses T-Mobile and its partners’ networks (GPRS) to send data to the BIOTRONIK Service Centre from where the data is sent to the physician.
“Home Monitoring has helped doctors world over to keep a very close look at their patients implanted devices and their cardiac activity. It has helped reduced mortality, episodes of hospitalizations and inappropriate shocks and helped improve the quality of life of patients immensely. It helps use of the full potential of the device that preserves battery life. It has also helped reduce routine clinic follow up, which can be a burden to patients and extra workload for physicians. These results formed basis for the Class I A indication, which means this is considered as standard of best care. This was the recommendation by the Heart Rhythm Society and is endorsed by the other professional societies around the world, including Asia Pacific Heart Rhythm Society.” said Dr Niraj Varma, Electrophysiologist at Cleveland Clinic, Ohio, USA who co-chaired this document.
Dr Varma says Home Monitoring has clinically shown to have helped doctors provide improved services and helped better the health conditions of patients
The CardioMessenger® Smart facilitates the application of Home Monitoring.
Results from large clinical show the following benefits of Home Monitoring: